Published in Cell on November 19, 2015
A guide to immunometabolism for immunologists. Nat Rev Immunol (2016) 1.41
The microbiota in adaptive immune homeostasis and disease. Nature (2016) 1.18
Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. Nat Rev Immunol (2016) 1.15
An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage. Nat Neurosci (2016) 0.98
CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol (2016) 0.97
Regulation of the T Cell Response by CD39. Trends Immunol (2016) 0.83
The dichotomous nature of T helper 17 cells. Nat Rev Immunol (2017) 0.81
Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med (2017) 0.81
Distinctive expression of interleukin-23 receptor subunits on human Th17 and γδ T cells. Immunol Cell Biol (2016) 0.76
T cell responses in the central nervous system. Nat Rev Immunol (2017) 0.76
Metabolic Instruction of Immunity. Cell (2017) 0.76
T Helper 17 Cells in Primary Sjögren's Syndrome. J Clin Med (2017) 0.76
Immunometabolic Regulation of Interleukin-17-Producing T Helper Cells: Uncoupling New Targets for Autoimmunity. Front Immunol (2017) 0.75
Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases. Gastroenterology (2016) 0.75
An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition. JCI Insight (2017) 0.75
Transcriptomic signatures decode Th17 cell pathogenicity. Cell Mol Immunol (2016) 0.75
Interplay of Regulatory T Cell and Th17 Cells during Infectious Diseases in Humans and Animals. Front Immunol (2017) 0.75
CD4(+) T Cell Fate in Glomerulonephritis: A Tale of Th1, Th17, and Novel Treg Subtypes. Mediators Inflamm (2016) 0.75
A proteolytic modification of AIM promotes its renal excretion. Sci Rep (2016) 0.75
T cells: Seq-ing out the 'bad' guys. Nat Rev Immunol (2015) 0.75
Selective Induction of Homeostatic Th17 Cells in the Murine Intestine by Cholera Toxin Interacting with the Microbiota. J Immunol (2017) 0.75
Low-dose controlled release of mTOR inhibitors maintains T cell plasticity and promotes central memory T cells. J Control Release (2017) 0.75
A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease. JCI Insight (2017) 0.75
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications. Genome Med (2017) 0.75
Th17 Polarization under Hypoxia Results in Increased IL-10 Production in a Pathogen-Independent Manner. Front Immunol (2017) 0.75
Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors. J Biol Chem (2017) 0.75
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 29.29
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med (2005) 28.73
Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature (2003) 22.89
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet (2003) 14.56
TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol (2007) 11.14
The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol (2008) 7.91
Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature (2010) 7.50
Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol (2012) 7.37
Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity (2009) 6.87
The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol (2009) 6.74
Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med (2003) 6.73
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med (2012) 6.17
Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science (2009) 6.07
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med (2012) 6.01
HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med (2011) 5.99
Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol (2007) 5.99
Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell (2011) 5.63
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 5.47
Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol (2007) 5.14
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature (2013) 4.74
Induction and molecular signature of pathogenic TH17 cells. Nat Immunol (2012) 4.43
A module of negative feedback regulators defines growth factor signaling. Nat Genet (2007) 4.35
Immunity to fungal infections. Nat Rev Immunol (2011) 4.33
Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol (2009) 3.88
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature (2012) 3.85
Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol (2009) 3.49
Dynamic regulatory network controlling TH17 cell differentiation. Nature (2013) 3.07
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum (2010) 2.99
New IBD genetics: common pathways with other diseases. Gut (2011) 2.95
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med (2014) 2.13
Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity (2011) 2.11
Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms. Immunity (2014) 2.09
Obesity predisposes to Th17 bias. Eur J Immunol (2009) 2.04
Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med (1999) 2.01
c-Maf regulates IL-10 expression during Th17 polarization. J Immunol (2009) 1.99
Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma. Mol Endocrinol (2010) 1.98
Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature (2014) 1.81
Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis (2012) 1.77
The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. Crit Rev Immunol (2004) 1.59
Minreg: inferring an active regulator set. Bioinformatics (2002) 1.33
The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol (2013) 1.29
Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab (2010) 1.27
IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev (2010) 1.23
Identification of natural RORγ ligands that regulate the development of lymphoid cells. Cell Metab (2015) 1.10
Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice. J Nutr (2011) 1.08
Balancing acts: the role of TGF-β in the mucosal immune system. Trends Mol Med (2011) 1.06
IL-17 signaling in host defense against Candida albicans. Immunol Res (2011) 1.06
Th17 cytokines in mucosal immunity and inflammation. Curr Opin HIV AIDS (2010) 0.98
The macrophage soluble receptor AIM/Api6/CD5L displays a broad pathogen recognition spectrum and is involved in early response to microbial aggression. Cell Mol Immunol (2014) 0.97
Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation. Proc Natl Acad Sci U S A (2014) 0.97
How Cytokine networks fuel inflammation: Interleukin-17 and a tale of two autoimmune diseases. Nat Med (2013) 0.94
Induction of IL-17A Precedes Development of Airway Hyperresponsiveness during Diet-Induced Obesity and Correlates with Complement Factor D. Front Immunol (2014) 0.88
n3 PUFAs reduce mouse CD4+ T-cell ex vivo polarization into Th17 cells. J Nutr (2013) 0.87
Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation. Exp Mol Med (2012) 0.83
Unexpected targets and triggers of autoimmunity. J Clin Immunol (2014) 0.80